This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Andrew Jason Glowacki
Introduction
Andrew Jason Glowacki is a notable inventor based in Pittsburgh, PA, who has made significant strides in the field of biomedical engineering. With a total of four patents to his name, Glowacki's work focuses on advanced drug delivery systems and their applications in treating various medical conditions. His innovative approaches have the potential to revolutionize therapeutic strategies in the medical field.
Latest Patents
Glowacki's latest patents include groundbreaking research on the controlled release of vasoactive intestinal peptide (VIP) from microparticles. This method utilizes different polymer molecular sizes and solutes to enhance the bioactivity of released VIP, which has shown promising results in increasing the production of CCL22 by dendritic cells. Additionally, his research indicates that VIP microparticles can significantly reduce bone loss in infected mice, highlighting their therapeutic potential for treating periodontal disease. Another notable patent involves a biomimetic drug delivery system for ocular conditions, which aims to recruit regulatory T cells to specific ocular regions, thereby improving treatment outcomes for patients with ocular disorders.
Career Highlights
Glowacki is affiliated with the University of Pittsburgh, where he continues to advance his research in drug delivery systems. His work has garnered attention for its innovative approach to addressing complex medical challenges. The impact of his inventions is evident in the promising results observed in both in vitro and in vivo studies.
Collaborations
Glowacki collaborates with esteemed colleagues, including Steven R. Little and Michelle L. Guaragno, who contribute to the multidisciplinary approach of his research. Their combined expertise enhances the potential for developing effective therapeutic solutions.
Conclusion
Andrew Jason Glowacki's contributions to the field of biomedical engineering through his innovative patents and research collaborations position him as a key figure in advancing drug delivery technologies. His work not only addresses current medical challenges but also paves the way for future innovations in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile